PHARM Week 3 project.pptx - Pharmacological Management of Gram-Positive Infections Nadine Nufer(Week 3 NSG6005 Advanced Pharmacology SU08 Gram-Positive

PHARM Week 3 project.pptx - Pharmacological Management of...

This preview shows page 1 - 4 out of 6 pages.

Pharmacological Management of Gram-Positive Infections Nadine Nufer (Week 3) NSG6005 Advanced Pharmacology SU08
Image of page 1
Gram-Positive Infections A recent survey showed that GPC (gram-positive cocci) causes the majority of nosocomial infections with Staphylococcus aureus (16%, with more than 50% being methicillin-resistant) and Enterococcus species (14%, with vancomycin- resistant enterococci accounting for approximately 3.5% of all infections) predominating. New resistance patterns are also emerging to include vancomycin intermediate Staphylococcus aureus. Given these new resistance patterns, testing for susceptibility and adequate antibiotic dosing are of importance for proper management of infected patients (Sievert et al.,2013). Gram-positive cocci cause certain infections Pneumococcal Staphylococcal aureus Streptococcal Toxic shock syndrome (Woo, 2015).
Image of page 2
Pharmacological Management with Lipoglycopeptides Vancomycin IV: Treatment of potentially life-threatening infections when less toxic anti- infectives are contraindicated. Particularly useful in staphylococcal infections, including: Endocarditis, Meningitis, Osteomyelitis, Pneumonia, Septicemia,
Image of page 3
Image of page 4

You've reached the end of your free preview.

Want to read all 6 pages?

  • Fall '16
  • Bacteria, Staphylococcus aureus, PHARMACOLOGICAL MANAGEMENT, skin/skin structure infections, new resistance patterns

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

Stuck? We have tutors online 24/7 who can help you get unstuck.
A+ icon
Ask Expert Tutors You can ask You can ask You can ask (will expire )
Answers in as fast as 15 minutes